Av. Prof. Lineu Prestes, 1730 – Butantã – São Paulo/SP – CEP 05508-000. Instituição de ensino, pesquisa e extensão. Possui 2 cursos graduação, 6 programas de pós-graduação, além de …

O ICB recomenda a observação da DORA em todos seus processos seletivos. Pesquisa do ICB-USP identifica relação entre falhas respiratórias e sono e aponta estimulação cerebral seletiva como alternativa promissora.

The Laboratory of Transplantation Immunobiology (L.I.T) was created in August 2005 within the Department of Immunology, at the Institute of Biomedical Sciences IV, at the University of Sao Paulo. The group started with the primary objective of studying the immunological factors that adversely affect the survival of organ transplant recipients.

免疫检查点阻断 (ICB)已被证实对DNA错配修复缺陷 (dMMR)/微卫星高度不稳定 (MSI- H)的 CRC有效，但对没有错配修复缺陷 (pMMR)/微卫星稳定 (MSS) 的CRC无效。 但是，目前没有真实世界的研究数据。 因此，来自中山大学肿瘤医院研究团队开展了一项真实世界回顾性研究，评估免疫检查点阻断 (ICB)在CRC的疗效和毒性。 相关结果发表在Cancer Communications杂志上。 研究纳入2017年3月1日至2019年10月1日在中山大学肿瘤医院接受ICB治疗的69例CRC患者。 其中52 …

2019年2月7日 · The ICB III conference brought together leading scientists and engineers from academia, industry and regulatory authorities that are actively engaged in continuous bioprocessing to debate how industrialized our sector can become and potential scenarios where continuous platforms will better serve our needs.

2023年9月1日 · icb在以高新抗原负荷为特征的错配修复缺陷（mmrd）的癌症患者中具有显著的临床活性，并且其在围手术期环境中在该亚组中的使用是密集临床研究的领域。

近期，免疫治疗的先驱者Alan J. Korman在Nature review drug discovery杂志上发表了一篇名为“The foundations of immune checkpoint blockade and the ipilimumab approval decennial”的文章，Alan J.Korman回顾了 免疫检查点阻断疗法 （ICB）的基础科学史，以及第一代靶向药物CTLA4和PD1的发现、开发 ...

Leveraging Sanofi intensified ICB platform to enable early process development for a labile and hard-to-express molecule, Jiuyi Lu, Daryl Powers, Nathan Ostberg, Emily Davenport, Jason Walther, Kevin Brower, and Jean McLarty (Abstract)

2022年3月15日 · 近些年，免疫检查点阻断（immune checkpoint blockade，ICB）在肿瘤治疗中取得了重要进展。但是，仅部分患者对治疗有应答，部分应答时间不理想，部分因免疫相关不良反应（irAEs）中断治疗等。宿主内在和外在因素对ICB应答、耐药、毒性方面会产生怎样的影 …

ICB IV (Av. Prof. Lineu Prestes , nº 1730 – Butantã – São Paulo/SP – CEP 05508-000)